<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:department>London Research Institute (LIF)</gtr:department><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F4EA387A-E17F-480F-9E7A-5C78C6BCD9DB"><gtr:id>F4EA387A-E17F-480F-9E7A-5C78C6BCD9DB</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Cherepanov</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900116"><gtr:id>DEDBD80A-DB5A-4855-9FFF-8FD820A24CAC</gtr:id><gtr:title>Structural Biology of Retroviral DNA Integration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900116</gtr:grantReference><gtr:abstractText>To achieve productive infection, HIV must insert a DNA copy of its genome into a chromosome of a human cell. This complex process is orchestrated by integrase, an enzyme carried by the virus. Once integration is complete, the viral genome becomes a permanent resident in a cellular chromosome. From there it will initiate production of new infectious particles or it might stay dormant and undetected for a long period of time. The integration is partly responsible for the notable persistence of retroviral infections. Yet, the dependence of HIV on integration is also an exploitable weakness. A new class of drugs, disrupting enzymatic activity of integrase, called strand transfer inhibitors, takes advantage of this weakness to fight HIV infection. The three-dimensional atomic structure of HIV integrase is not known and even less understood is the architecture of its active form during integration process. Currently, the lack of structural information is the major impediment to the development of strand transfer inhibitors. This project aims to elucidate the three-dimensional structure of integrase. We will determine atomic structures of this protein separately and in active, DNA-bound, form. To achieve our goals we will use X-ray crystallography, which allows visualization of protein molecules, although requiring a significant amount of preparatory work. In particular, to determine high-resolution structures, we will have to obtain crystals of integrase in complex with accessory proteins and/or DNA. Our results will be published in open access journals and the data will be accessible to the scientific community via public databases. Our research will generate dat, which will be of great value for drug discovery by both academic and private groups, and will serve to reduce the costs and improve availability of the eventual treatments.</gtr:abstractText><gtr:technicalSummary>DNA integration is an essential step in retroviral replication, orchestrated by integrase (IN). This virally-encoded enzyme is a validated target for development of antivirals, and the first IN inhibitor has been recently approved for treatment of HIV infection. Currently, the major obstacle for the development of this promising class of drugs is the lack of structural information. Only partial structures of HIV IN have been reported; even less understood is the architecture of the active IN-DNA complex. Given that the inter-subunit/domain interfaces observed in existing partial structures have not been verified by functional assays or through examination of alternative crystal forms, there is not enough experimental data to assemble an unambiguous model of the active IN complex. This 3-year study aims at elucidating the structural basis for retroviral integration through X-ray crystallography and functional studies. We propose to (i) characterize/validate inter-subunit interfaces observed in existing IN structures; (ii) determine crystal structures of a full-length lentiviral IN in complex with its co-factor LEDGF; (iii) determine a crystal structure of a full-length IN in complex with its cognate DNA; and (iv) characterize the interaction between HIV-1 IN and the putative lentiviral nuclear import receptor Tnpo3.</gtr:technicalSummary><gtr:fund><gtr:end>2012-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>616486</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>several interviews following publication of a recent article in Nature</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>265E95C6-951D-483D-A927-290A9190CE98</gtr:id><gtr:impact>news websites worldwide

n/a</gtr:impact><gtr:outcomeId>mqV5TfYx4mE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>288692</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU FP7 HEALTH-2012-INNOVATION-1 collaborative project</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305137 HIVINNOV</gtr:fundingRef><gtr:id>D13D495D-24F1-44C6-94A9-5778BD073257</gtr:id><gtr:outcomeId>YCvMYpGhb3e</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>686400</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>National Institute of General Medical Sciences (NIGMS)</gtr:department><gtr:description>NIH P50 Center Grant</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>2P50GM082251-06</gtr:fundingRef><gtr:id>4E41EC93-425A-49D5-959E-2C3E4B9ADC28</gtr:id><gtr:outcomeId>pQZ92YxkimE</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>239000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>067757DB-7F3F-4127-92CA-FD92AA837574</gtr:id><gtr:outcomeId>ee8XBjZbA8E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>304185D7-C26C-4406-BE1A-ACC05EDB75AC</gtr:id><gtr:title>Integrase residues that determine nucleotide preferences at sites of HIV-1 integration: implications for the mechanism of target DNA binding.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ed97b2dd4bedf9e55fe495ea740222f"><gtr:id>7ed97b2dd4bedf9e55fe495ea740222f</gtr:id><gtr:otherNames>Serrao E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5461ec62d98c36.88485061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01E0C70D-9BA8-4CCA-B0F7-12DBC072C213</gtr:id><gtr:title>The mechanism of retroviral integration from X-ray structures of its key intermediates.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c749d627f6a6bccbe386923cc5a048"><gtr:id>67c749d627f6a6bccbe386923cc5a048</gtr:id><gtr:otherNames>Maertens GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>D1EHBAn1AQo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42162230-058C-49A8-A42C-3327D7AD7CED</gtr:id><gtr:title>Retroviral intasome assembly and inhibition of DNA strand transfer.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425a4d328ce2edcb596c40787925c07"><gtr:id>2425a4d328ce2edcb596c40787925c07</gtr:id><gtr:otherNames>Hare S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>LtZqidLMM4h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ECCFAE3-D858-43AE-81B6-F75CE4F65ED3</gtr:id><gtr:title>The structural biology of HIV-1: mechanistic and therapeutic insights.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7556856c4f70836893ec054ab43f8aab"><gtr:id>7556856c4f70836893ec054ab43f8aab</gtr:id><gtr:otherNames>Engelman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>pm_16530_20_22421880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A20F1D2C-65CA-4AD3-8B05-BD9958805D49</gtr:id><gtr:title>Structural biology of retroviral DNA integration.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93f8556619f3487d06c35513ec7d86fb"><gtr:id>93f8556619f3487d06c35513ec7d86fb</gtr:id><gtr:otherNames>Li X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>H8pVUN9hc6Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C6DA603-2169-4745-85D1-FE42BDADD513</gtr:id><gtr:title>Crystal structure of human CDC7 kinase in complex with its activator DBF4.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69df773c643fd4394faef6039c278245"><gtr:id>69df773c643fd4394faef6039c278245</gtr:id><gtr:otherNames>Hughes S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_16530_20_23064647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6680DF63-9787-4598-B42F-93BA8E48A58E</gtr:id><gtr:title>Structural insights into the retroviral DNA integration apparatus.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2459210727b755d74eb3437f6b1b30aa"><gtr:id>2459210727b755d74eb3437f6b1b30aa</gtr:id><gtr:otherNames>Cherepanov P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>h5XccZj88Rd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE348D62-BDB1-43F3-AF1D-755238882E1C</gtr:id><gtr:title>Integrase illuminated.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2459210727b755d74eb3437f6b1b30aa"><gtr:id>2459210727b755d74eb3437f6b1b30aa</gtr:id><gtr:otherNames>Cherepanov P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>pm_16530_20_20428106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E39BFDB9-7E00-4D48-B3CD-88D4DE1A3504</gtr:id><gtr:title>Retroviral Integrase Structure and DNA Recombination Mechanism.</gtr:title><gtr:parentPublicationTitle>Microbiology spectrum</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7556856c4f70836893ec054ab43f8aab"><gtr:id>7556856c4f70836893ec054ab43f8aab</gtr:id><gtr:otherNames>Engelman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2165-0497</gtr:issn><gtr:outcomeId>5675e721e5008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BC59999-B87F-4BD0-A3C2-F1295F1338A8</gtr:id><gtr:title>Structure-based modeling of the functional HIV-1 intasome and its inhibition.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b969b35768aaa4e1966e9fe8450e83c"><gtr:id>3b969b35768aaa4e1966e9fe8450e83c</gtr:id><gtr:otherNames>Krishnan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>dhvpwJwrws1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>910B9FD7-9193-47E1-A7A5-77ADD0D622A8</gtr:id><gtr:title>Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425a4d328ce2edcb596c40787925c07"><gtr:id>2425a4d328ce2edcb596c40787925c07</gtr:id><gtr:otherNames>Hare S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>guhtiQy3UYD</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900116</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>